Cannage Capital

Cannage Capital is a Las Vegas, Nevada-based venture capital firm that provides funding to early-stage companies operating across the artificial intelligence stack, cybersecurity, biotechnology, data-driven healthcare, and financial technology sectors. The organization currently manages 1 active investment vehicle in the market, Cannage Capital I, which opened to limited partners in May 2024. The firm focuses its capital allocation strategy on founders building comprehensive hardware and software infrastructure, ranging from advanced semiconductor manufacturing to consumer technology and enterprise software applications. The firm's leadership team, which includes partner Jake Smith, leverages prior experience at other venture funds to identify high-growth market opportunities across these industries. The organization's investment portfolio features several prominent technology and life sciences companies, including Covariant, Cruise Automation, Ginkgo Bioworks, and Hinge Health. Cannage Capital was established in 2024 by founding partner Shelly Zhuang.